Intriguingly, these favorable changes occurred without a decrease in blood pressure or cardiac hypertrophy, suggesting a direct beneficial effect on myocyte function (6).
relevant to the contents of this paper to disclose. and pulmonary vascular dysfunction (13) (14) (15) , and abnormalities in the periphery (16, 17) . Indeed, it has been suggested that the tremendous mechanistic heterogeneity in HFpEF requires more rigorous subphenotyping to get the right treatment to the right patient (18, 19) . It would be interesting to see if CDCs might affect these other crucial components in the pathophysiology.
J A C C : B A S I C T O T R A N S L A T I O N A L S C I
E N C E VOL. 1, NO. 1-2, 2016 ª 2 0 1 6
T H E A U T H O R S . P U B L I S H E D B Y E L S E V I E R O N B E H A L F O F T H E A M E R I C A N C O L L E G E O F C A R D I O L O G Y F O U N D A T I O N . T H I S I S A N O P E N A C C E S S A R T I C L E U N D E R T H E C C B Y -N C -N D L I C E N S E ( h t t p : / / c r e a t i v
The data from Gallet et al. (6) 
